UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042713
Receipt number R000048749
Scientific Title Effectiveness of body contouring surgery for massive weight loss after bariatric surgery
Date of disclosure of the study information 2021/03/01
Last modified on 2021/03/27 10:42:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effectiveness of body contouring surgery for massive weight loss after bariatric surgery

Acronym

Effectiveness of body contouring surgery

Scientific Title

Effectiveness of body contouring surgery for massive weight loss after bariatric surgery

Scientific Title:Acronym

Effectiveness of body contouring surgery

Region

Japan


Condition

Condition

Patients suffering from discomfort caused by the excessive skin for massive weight loss following bariatric surgery

Classification by specialty

Plastic surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate patient satisfaction of body contouring surgery for massive weight loss after bariatric surgery

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Assessment of patient satisfaction comparing preoperative and post op. 12 month Body-Q score

Key secondary outcomes

Post operative complications


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

surgical resection of skin fold

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1.Patients suffering from skin folds after massive weight loss
2.Patients are followed over one year after massive weight loss. Consecutive 3 monthly body weight changes are within 5 % of excessive body weight. The calculation of excessive body weight are pre-treatment weight minus ideal body weight.
3.The patient's skin condition must present a significant functional disturbance(both physical and psychological.
3.1.difficulty of physical motion
3.2.chronic shoulder pain
3.3 skin pathology
4.Refersal from bariatric surgeon or a family doctor
5. Can fill out Body-Q
6. ASA class 1 and 2
7. Currently non-smoker

Key exclusion criteria

1, severe cardiac failure, major pulmonary dysfunction
2, patients who cannot be followed or denied to be followed up
3, pregnant patients
4, patients with coagulopathy
5, patients who are attending other experimental protocol

Target sample size

24


Research contact person

Name of lead principal investigator

1st name yoshimichi
Middle name
Last name Imai

Organization

Graduate School of Medicine, Tohoku University

Division name

Department of Plastic and Reconstructive Surgery

Zip code

980-8575

Address

2-1, Seiryo-machi, Aoba-ku, Sendai,

TEL

022-717-7332

Email

yo-imai@med.tohoku.ac.jp


Public contact

Name of contact person

1st name koreyuki
Middle name
Last name Kurosawa

Organization

Graduate School of Medicine, Tohoku University

Division name

Department of Plastic and Reconstructive Surgery

Zip code

980-8575

Address

2-1, Seiryo-machi, Aoba-ku, Sendai,

TEL

022-717-7332

Homepage URL


Email

koreyuki.kurosawa.a1@tohoku.ac.jp


Sponsor or person

Institute

Graduate School of Medicine, Tohoku University

Institute

Department

Personal name



Funding Source

Organization

Management Expenses Grants

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

ethical board of Tohoku University hospital

Address

1-1, Seiryo-machi, Aoba-ku, Sendai

Tel

02277284105

Email

rinri-esct@proj.med.tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東北大学病院、千葉大形成外科、東邦大大森病院形成外科、愛媛大形成外科、大分大形成外科


Other administrative information

Date of disclosure of the study information

2021 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2020 Year 12 Month 09 Day

Date of IRB


Anticipated trial start date

2021 Year 06 Month 01 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 12 Month 10 Day

Last modified on

2021 Year 03 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048749


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name